Back
Arcellx Vs. AbbVie Industry Stock Comparison
Sell
14
ACLX
Arcellx
Last Price:
$75.42
Seasonality Move:
14.38%
Sell
40
ABBV
AbbVie
Last Price:
$175.68
Seasonality Move:
1.78%
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
-
ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACLX Stock Price Chart
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.25 | Sell |
Relative Strength Index (14 RSI): | 34.86 | Sell |
Chaikin Money Flow: | 623628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.73 - 90.33) | Sell |
Bollinger Bands (100): | (67.95 - 91.95) | Sell |
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.42 | Sell |
Relative Strength Index (14 RSI): | 46.96 | Sell |
Chaikin Money Flow: | 10543412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (169.89 - 179.79) | Buy |
Bollinger Bands (100): | (178.35 - 198.21) | Sell |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.74 | Sell |
20-day SMA: | 85.01 | Sell |
50-day SMA: | 88.53 | Sell |
200-day SMA: | 69.02 | Buy |
8-day EMA: | 79.52 | Sell |
20-day EMA: | 83.53 | Sell |
50-day EMA: | 84.84 | Sell |
200-day EMA: | 71.83 | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 173.51 | Buy |
20-day SMA: | 176.68 | Sell |
50-day SMA: | 182.88 | Sell |
200-day SMA: | 178.79 | Sell |
8-day EMA: | 174.1 | Buy |
20-day EMA: | 175.92 | Sell |
50-day EMA: | 180.64 | Sell |
200-day EMA: | 178.22 | Sell |
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and a decrease next year of $0.73 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.24 per share.
Arcellx Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AbbVie Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |